Critical illness-related corticosteroid insufficiency in cardiogenic shock.
R
R
Aslam
N
N
Ducrocq
C
C
Thivilier
P
P
Perez
A
A
Gerard
A
A
Kimmoun
B
B
Levy
D000309:Adrenal Insufficiency / Q000150:complications* / Q000188:drug therapy*; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D016638:Critical Illness; D004837:Epinephrine / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006629:Hirudins; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D017257:Ramipril / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology*; D013876:Thiophenes / Q000627:therapeutic use; D016896:Treatment Outcome
D000316:Adrenergic alpha-Agonists; D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D006629:Hirudins; D010446:Peptide Fragments; D010879:Piperazines; D011994:Recombinant Proteins; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride; D017257:Ramipril; D001241:Aspirin; C074619:bivalirudin; D006854:Hydrocortisone; D017298:Bisoprolol; D004837:Epinephrine